NAV
₹355.3036
as of 17 Jun 2026
Expense Ratio
—
see scheme documents
Viewing Direct · Growth
Lumpsum returns (CAGR)
- 1Y
- +12.08%
- 3Y
- +26.23%
- 5Y
- +15.61%
- Since Inception
- +16.10%
SIP returns (XIRR)
- 1Y
- +18.41%
- 3Y
- +18.56%
- 5Y
- +19.48%
- Since Inception
- +13.08%
Performance Comparison
Sectoral allocation
as of 31 Mar 2026Each sector links to the mutual funds most exposed to it.
Thinking about UTI Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Compare All Sectoral / Thematic FundsView all Sectoral / Thematic funds
Fund Details
Fund HouseUTI Mutual Fund
CategorySectoral / Thematic
Launch Date01 Jan 2013
AMFI Code120782
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹500
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
Portfolio holdings
as of 31 Mar 2026
portfolio shared with UTI Healthcare Fund - Regular Plan - Growth Option
Holding% NAV
- 1Sun Pharmaceuticals Industries9.99%
- 2Ajanta Pharma Ltd.6.40%
- 3Lupin Ltd.5.92%
- 4Glenmark Pharmaceuticals Ltd.4.04%
- 5Apollo Hospitals Enterprise Lt3.73%
- 6Gland Pharma Ltd.3.46%
- 7Dr Reddys Laboratories Ltd.3.45%
- 8Divis Laboratories Ltd.3.42%
- 9Alkem Laboratories Ltd3.41%
- 10Fortis Healthcare Ltd.3.01%
Rows per page· 43 total
Page 1/5
Investment Objective
UTI Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
UTI Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by UTI Mutual Fund. The fund has been operational for over 13 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations